Pedro Pesini
Corporate Officer/Principal bei Araclon Biotech SL
Ursprung des Netzwerks ersten Grades von Pedro Pesini
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Araclon Biotech SL
Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pedro Pesini
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
GRIFOLS, S.A. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
University of Zaragoza | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
BIOTEST AG | Pharmaceuticals: Other | Director/Board Member | |
Pbs Acquisition Corp. | Director/Board Member | ||
BPC Plasma, Inc.
BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Director/Board Member | |
Osborne Clarke
Osborne Clarke Miscellaneous Commercial ServicesCommercial Services Osborne Clarke is a Spanish company that offers legal services to various sectors including life sciences, tech, media and communications, renewable energy, financial services and real estate. The private company is based in Madrid, Spain. The company was founded by Tomás Dagá Gelabert. | Miscellaneous Commercial Services | Founder | |
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | Biotechnology | Director/Board Member | |
Grifols Canada Therapeutics, Inc.
Grifols Canada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Grifols Canada Therapeutics, Inc. is a Canadian company that produces plasma-derived medicines. The company is based in Saint-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Instituto de Empresa SL | College/University | Masters Business Admin | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
Chiquito Acquisition Corp. | Director/Board Member | ||
University of Hannover | College/University | Doctorate Degree | |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | Miscellaneous Commercial Services | Director/Board Member | |
Gri-Cel SA
Gri-Cel SA Financial ConglomeratesFinance Part of Grifols SA, Gri-Cel SA provides investment services. The company is based in Barcelona, Spain. The CEO of the Spanish company is Dirk Büscher. | Financial Conglomerates | Chief Executive Officer | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
Institut Químic De Sarrià | College/University | Undergraduate Degree | |
Grifols Innovation & New Technologies Ltd.
Grifols Innovation & New Technologies Ltd. BiotechnologyHealth Technology Grifols Innovation & New Technologies Ltd. provides research and experimental development services in biotechnology sector. The company was founded on December 21, 2015 and is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member | |
Alkahest, Inc.
Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Grifols USA, Inc.
Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | Medical Specialties | Director/Board Member | |
Tojosnura SL
Tojosnura SL Miscellaneous Commercial ServicesCommercial Services Tojosnura SL provides legal services. The company was founded by Tomas Daga Gelabert and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Founder | |
University of Barcelona | College/University | Graduate Degree | |
Scranton Enterprises BV
Scranton Enterprises BV Investment ManagersFinance Scranton Enterprises BV is a private equity firm with its headquarters in Amsterdam, the Netherlands. | Investment Managers | Director/Board Member | |
Zambon SA | Medical Distributors | Director/Board Member | |
Pharmazam SA | Director/Board Member | ||
Barcelona Cartonboard S.A.U.
Barcelona Cartonboard S.A.U. Pulp & PaperProcess Industries Barcelona Cartonboard S.A.U. manufactures and supplies cardboard. It produces cardboard made from recycled fibres and virgin fibers for various sectors, including the hardware and cleaning, textile, food, pharmacy and graphic sectors. The company was founded in 1967 and is headquartered in Castellbisbal, Spain. | Pulp & Paper | Director/Board Member | |
Joaquim Molins Figueras Foundation | Director/Board Member | ||
Kiro Grífols SL
Kiro Grífols SL Packaged SoftwareTechnology Services Part of Grifols SA, Kiro Grífols SL is a Spanish company located in Arrasate that provides automated robotics technology. On July 24, 2017 Grifols SA acquired Kiro Grífols SL from Mondragon S. Coop for $14.92 million. | Packaged Software | Director/Board Member | |
Progenika Biopharma SA
Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Medical Specialties | Corporate Secretary | |
Biomat USA, Inc.
Biomat USA, Inc. Medical/Nursing ServicesHealth Services Biomat USA, Inc. provides plasma derived blood products. The company is headquartered in Los Angeles, CA. | Medical/Nursing Services | Director/Board Member | |
Talecris Plasma Resources, Inc.
Talecris Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Part of Grifols SA, Talecris Plasma Resources, Inc. owns and operates plasma collection centers. The company is based in Toledo, OH. | Medical/Nursing Services | Director/Board Member | |
Grifols Diagnostic Solutions, Inc.
Grifols Diagnostic Solutions, Inc. Pharmaceuticals: MajorHealth Technology Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Director/Board Member | |
Grifols Worldwide Operations Ltd.
Grifols Worldwide Operations Ltd. Pharmaceuticals: MajorHealth Technology Grifols Worldwide Operations Ltd. manufactures and develops pharmaceutical products. The company was founded in 2013 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Fundació Víctor Grífols I Lucas | Director/Board Member | ||
Probitas Foundation
Probitas Foundation Miscellaneous Commercial ServicesCommercial Services Probitas Foundation promotes and finances various activities and cooperative programs to improve healthcare. The private company is based in Barcelona, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
UCD Michael Smurfit Graduate School of Business | College/University | Graduate Degree |
Statistik
International
Spanien | 19 |
Vereinigte Staaten | 8 |
Irland | 4 |
Deutschland | 3 |
Kanada | 3 |
Sektoral
Health Technology | 14 |
Consumer Services | 7 |
Commercial Services | 5 |
Finance | 3 |
Health Services | 3 |
Operativ
Director/Board Member | 28 |
Corporate Officer/Principal | 5 |
Corporate Secretary | 4 |
Founder | 3 |
Chief Executive Officer | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Pedro Pesini
- Unternehmensverbindungen